Released May 12, 2020, after the close
10-Q filed May 13, 2020, 43 days after period end · 0001636422-20-000049
Q1 2020 · 10-Q
Revenue$45.12M$45.12M +28.1% vs Q1 2019+3.7% vs Q4 2019
Net Income-$17.49M-$17.49M N/M vs Q1 2019N/M vs Q4 2019
EPS Diluted-$0.47-$0.47 N/M vs Q1 2019no prior Q4 2019 on file
Operating Income-$18,105,000N/M
Operating Cash Flow-$16,769,000N/M
Free Cash Flowderived-$17,197,000N/M
Margins · derived
Operating margin-40.1%−8.6 pt vs Q1 2019
Net margin-38.8%+0.2 pt vs Q1 2019
What the release said
The release
Same quarter
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Revenue | $45.12M | $35.21M |
| Net Income | -$17.49M | -$13.72M |
| EPS Diluted | -$0.47 | -$16.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR